A new cis element is involved in the HER2 gene overexpression in human breast cancer cells

Madeleine Grooteclaes; Douglas Vernimmen; Serge Plaza; Françoise Pasleau; Didier Hodzic; Rosita Winkler-Gol

A new cis element is involved in the HER2 gene overexpression in human breast cancer cells

Madeleine Grooteclaes, Douglas Vernimmen, Serge Plaza, Françoise Pasleau, Didier Hodzic, Rosita Winkler-Gol

Research output: Contribution to journal › Article › peer-review

Abstract

The HER2 proto-oncogene product is overexpressed in 30% of breast cancers, and this correlates with poor prognosis. Increased levels of HER2 mRNA in breast cancer cell lines result from increased gene transcription. We report the identification of a new 17-bp-long cis sequence located between positions -506 and -489 from the transcription start site. This sequence is recognized by a trans-activating factor that we tentatively named HER2 transcription factor (HTF). This factor, involved in the increased transcription of the HER2 gene in the BT-474 mammary tumor cells, has a molecular weight of about M(r) 50,000. HTF can also bind, but with a lower affinity, to a related cis sequence present in the epidermal growth factor receptor promoter. Interestingly, the HTF binding activity is high in nuclear extracts from several mammary tumor cells overexpressing the HER2 gene.

Original language	English
Pages (from-to)	2527-2531
Number of pages	5
Journal	Cancer research
Volume	59
Issue number	11
State	Published - Jun 1 1999

Cite this

@article{7da5ac1fb79c4b23aab62381795e2ddb,

title = "A new cis element is involved in the HER2 gene overexpression in human breast cancer cells",

abstract = "The HER2 proto-oncogene product is overexpressed in 30% of breast cancers, and this correlates with poor prognosis. Increased levels of HER2 mRNA in breast cancer cell lines result from increased gene transcription. We report the identification of a new 17-bp-long cis sequence located between positions -506 and -489 from the transcription start site. This sequence is recognized by a trans-activating factor that we tentatively named HER2 transcription factor (HTF). This factor, involved in the increased transcription of the HER2 gene in the BT-474 mammary tumor cells, has a molecular weight of about M(r) 50,000. HTF can also bind, but with a lower affinity, to a related cis sequence present in the epidermal growth factor receptor promoter. Interestingly, the HTF binding activity is high in nuclear extracts from several mammary tumor cells overexpressing the HER2 gene.",

author = "Madeleine Grooteclaes and Douglas Vernimmen and Serge Plaza and Fran{\c c}oise Pasleau and Didier Hodzic and Rosita Winkler-Gol",

year = "1999",

month = jun,

day = "1",

language = "English",

volume = "59",

pages = "2527--2531",

journal = "Cancer research",

issn = "0008-5472",

number = "11",

}

TY - JOUR

T1 - A new cis element is involved in the HER2 gene overexpression in human breast cancer cells

AU - Grooteclaes, Madeleine

AU - Vernimmen, Douglas

AU - Plaza, Serge

AU - Pasleau, Françoise

AU - Hodzic, Didier

AU - Winkler-Gol, Rosita

PY - 1999/6/1

Y1 - 1999/6/1

N2 - The HER2 proto-oncogene product is overexpressed in 30% of breast cancers, and this correlates with poor prognosis. Increased levels of HER2 mRNA in breast cancer cell lines result from increased gene transcription. We report the identification of a new 17-bp-long cis sequence located between positions -506 and -489 from the transcription start site. This sequence is recognized by a trans-activating factor that we tentatively named HER2 transcription factor (HTF). This factor, involved in the increased transcription of the HER2 gene in the BT-474 mammary tumor cells, has a molecular weight of about M(r) 50,000. HTF can also bind, but with a lower affinity, to a related cis sequence present in the epidermal growth factor receptor promoter. Interestingly, the HTF binding activity is high in nuclear extracts from several mammary tumor cells overexpressing the HER2 gene.

AB - The HER2 proto-oncogene product is overexpressed in 30% of breast cancers, and this correlates with poor prognosis. Increased levels of HER2 mRNA in breast cancer cell lines result from increased gene transcription. We report the identification of a new 17-bp-long cis sequence located between positions -506 and -489 from the transcription start site. This sequence is recognized by a trans-activating factor that we tentatively named HER2 transcription factor (HTF). This factor, involved in the increased transcription of the HER2 gene in the BT-474 mammary tumor cells, has a molecular weight of about M(r) 50,000. HTF can also bind, but with a lower affinity, to a related cis sequence present in the epidermal growth factor receptor promoter. Interestingly, the HTF binding activity is high in nuclear extracts from several mammary tumor cells overexpressing the HER2 gene.

UR - http://www.scopus.com/inward/record.url?scp=0033153335&partnerID=8YFLogxK

M3 - Article

C2 - 10363966

AN - SCOPUS:0033153335

SN - 0008-5472

VL - 59

SP - 2527

EP - 2531

JO - Cancer research

JF - Cancer research

IS - 11

ER -

A new cis element is involved in the HER2 gene overexpression in human breast cancer cells

Abstract

Other files and links

Fingerprint

Cite this